THERMOGENESIS GETS HEALTH CANADA REGULATORY LICENSE TO MARKET AUTOXPRESS SYSTEM

The Medical Devices Bureau of Health Canada has issued ThermoGenesis a license to market the AutoXpress System in accordance with Health Canada's Medical Device Regulations. The specific regulations allows GE Healthcare, the AXP system distributor, to begin its sales and marketing effort to cord blood banks and hospitals in Canada.

"The AXO System is a newly developed automated system that allows stem cells from cord blood to be harvested in a functionally closed processing set without the requirement of expensive clean rooms and labor intensive processes," said Kevin Simpson, president and COO of ThermoGenesis.